ORBIMED ADVISORS LLC

Q1 2025 13F Holdings

  • Location
    new york, NY
  • Num holdings

    111

  • Value ($000)

    $4,194,646

  • Date Filed
    05/15/2025
  • Form type
    13F-HR
  • CIK
    0001055951
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

SINOVAC BIOTECH LTD

SHS
P8696W104
$334.00M
8 %

2,718,735

EWTX
EWTX

EDGEWISE THERAPEUTICS INC

COM
28036F105
$330.48M
8 %

15,021,721

BSX
BSX

BOSTON SCIENTIFIC CORP

COM
101137107
$283.80M
7 %

2,813,200

LLY
LLY

ELI LILLY & CO

COM
532457108
$278.83M
7 %

337,600

ELVN
ELVN

ENLIVEN THERAPEUTICS INC

COM
29337E102
$156.64M
4 %

7,959,538

ISRG
ISRG

INTUITIVE SURGICAL INC

COM NEW
46120E602
$144.12M
3 %

291,000

SYK
SYK

STRYKER CORPORATION

COM
863667101
$133.71M
3 %

359,200

ARGX
ARGX

ARGENX SE

SPONSORED ADR
04016X101
$122.34M
3 %

206,700

EW
EW

EDWARDS LIFESCIENCES CORP

COM
28176E108
$111.04M
3 %

1,532,000

UNH
UNH

UNITEDHEALTH GROUP INC

COM
91324P102
$105.38M
3 %

201,200

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 111